Zori, R. Et Al. 2024. Efficacy and safety of oral sepiapterin in participants with phenylketonuria on sapropterin dihydrochloride at time of Phase 3 aphenity study entry. MOLECULAR GENETICS AND METABOLISM , no.4 .

Zori, R., Lah, M., Offord, S., Lund, A., Opladen, T., Peters, H., ... Guilder, L.(2024). Efficacy and safety of oral sepiapterin in participants with phenylketonuria on sapropterin dihydrochloride at time of Phase 3 aphenity study entry. MOLECULAR GENETICS AND METABOLISM , no.4.

Zori, Roberto Et Al. "Efficacy and safety of oral sepiapterin in participants with phenylketonuria on sapropterin dihydrochloride at time of Phase 3 aphenity study entry," MOLECULAR GENETICS AND METABOLISM , no.4, 2024

Zori, Roberto Et Al. "Efficacy and safety of oral sepiapterin in participants with phenylketonuria on sapropterin dihydrochloride at time of Phase 3 aphenity study entry." MOLECULAR GENETICS AND METABOLISM , no.4, 2024

Zori, R. Et Al. (2024) . "Efficacy and safety of oral sepiapterin in participants with phenylketonuria on sapropterin dihydrochloride at time of Phase 3 aphenity study entry." MOLECULAR GENETICS AND METABOLISM , no.4.

@article{article, author={Roberto Zori Et Al. }, title={Efficacy and safety of oral sepiapterin in participants with phenylketonuria on sapropterin dihydrochloride at time of Phase 3 aphenity study entry}, journal={MOLECULAR GENETICS AND METABOLISM}, year=2024}